Post Surgical Neuropathic Pain clinical trials at UCSD
1 in progress, 0 open to eligible people
Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery
Sorry, not currently recruiting here
This is an interventional, Phase III, double-blind, randomized, controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and safety of repeated topical application of Qutenza (capsaicin 8% topical system) versus low-dose capsaicin control (capsaicin 0.04% topical system) in subjects with moderate to severe postsurgical neuropathic pain (PSNP).
La Jolla, California and other locations
Our lead scientists for Post Surgical Neuropathic Pain research studies include Mark Wallace.